Asplata Injection
PDF Leaflet Revision Date: 01 October 2015
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of advanced ovarian carcinoma and small cell lung carcinoma.
Dosage (summary)
400 mg/mu00b2 IV as a single dose; adjust for renal impairment and elderly.
Special Populations
- Elderly
- Renal impairment
Pregnancy & Breastfeeding
Contraindicated in pregnancy; safety in lactation not established.
Key Drug Interactions
- Cisplatin
- Nephrotoxic agents
- Live virus vaccines
Contraindications
- Hypersensitivity to carboplatin
- Severe renal impairment
- Pregnancy
Common side effects
- Myelosuppression
- Nausea
- Vomiting
- Allergic reactions
Counselling Points
- Avoid pregnancy during treatment
- Monitor for allergic reactions
- Do not drive if affected
Serious warnings
- Risk of anaphylaxis
- Myelosuppression monitoring required
Important Disclaimer
The Asplata Injection professional information leaflet below is the property of Aspen Pharmacare and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
